PHOENIX, AZ / ACCESSWIRE / July 30, 2015 / Months ago Uptick looked at Pressure BioSciences (OTCQB: PBIO), following the release of a Zacks
Small-Cap report from April on the company and the award of over a
million dollars in grant funding. In going over subsequent news from the
company, Q1 earnings, and additional Zacks reports, it is clear that Zacks target goal of $2.50 per share is appropriate, along with the estimation that PBIO shares are highly undervalued. Much of this interest in the company is based on the continued progress that PBIO
has made over this time on the development and commercialization of
their patented and enabling Pressure Cycling Technology (PCT) platform.

During the past two months, PBIO
announced that PCT-SWATH (a cutting-edge lab method that requires PCT as
an integral part of the method) is being utilized to identify new
protein biomarkers to more precisely
classify prostate cancer. This is especially important because patients
are typically classified into three groups: low-grade,
intermediate-grade and high-grade, and the intermediate-grade category
ends up including patients who progress on to high-grade, don’t show
progression and are re-categorized as low-grade, or remain intermediate
-grade. Dr. Nate Lawrence, Vice President of Marketing, and Sales for
the company stated, “this should enable more precise classification, which should lead to better prognosis and treatment.” Prostate cancer is the second most common cancer and the second leading
cause of cancer death in American men, per the American Cancer Society (ACS).
It is estimated that there will be approximately 220,800 new cases of
prostate cancer in 2015, with about 27,540 deaths. Based on current
statistics one man in thirty eight will die of prostate cancer. Clearly,
PBIO is poised to make an impact in that market, benefiting patients worldwide, while also benefitting stakeholders in the company.

PBIO also noted that their
PCT-based sample preparation was being used for selective differential
extraction of DNA recovered by cotton swabs, based on a study published
in Analytical and Bioanalytical Chemistry, a leading peer-reviewed scientific journal. Mr. Richard T. Schumacher, President and CEO of the company stated, “Future commercialization of this novel, PCT-based method could potentially provide significant new business channels for PBI in important forensic applications, such as touch DNA and rape kit testing.”

Commercialization of the PCT-based method could provide new revenue streams for PBIO
based on forensic needs. Estimates suggest there are hundreds of
thousands of untested rape kits ready for processing and analysis, not
taking into account new kits added to the list of kits needing testing
yearly. Forensic uses of the PBIO PTC
based method in labs across the US, performing thousands of tests
routinely, could potentially account for significant revenue growth for
the company, and help fix the un-acceptable backlog of untested rape
kits.

Furthermore, PBIO’s PCT based sample preparation solutions have been internationally recognized in Biochimica et Biophysica Acta, wherein the authors provided insights into “possible solutions for biomarker discovery and validation in the field of diabetes research.” These solutions could aid in early discovery, progression, and pathway
dysfunction that are vital in improving clinical outcomes. It is
estimated that the number of people worldwide with diabetes could
increase to a whopping 366 million by 2030.

PBIO’s PCT based solutions were also used in the identification of “multiple molecular pathways in COPD-associated lung cancer were presented at the recent American Society for Mass Spectrometry (“ASMS”) annual conference.” At the recent ASMS national meeting, PBIO
showcased their high-pressure instruments and consumables to over 800
visitors, “about 10x more than any previous year,” according to Dr.
Lawrence with PBIO. With the amount of potential exposure PBIO
received at that event alone, along with the published studies, there
is an expectation of strong continuing revenue growth for PBIO.

Beyond PBIO’s advances, there is
the matter of funds raised through an initial tranche that are planned
to increase the number of personnel in sales and marketing and retire a
significant portion of variable priced convertible debt that was taken
on during PBIO’s growth. In the March and May 2015 earnings calls, PBIO CFO Dick Thomley reported that revenue from the sale of PBI’s
products and services increased 29% EACH of the past two years, from
roughly $800,000 in 2012, to $1.1 million in 2013, to $1.375 million in
2014. The company also said it expects revenue to increase by even more
than 30% in 2015.

See the full May 2015 transcript here: http://seekingalpha.com/article/3201046-pressure-biosciences-pbio-ceo-richard-schumacher-on-q1-2015-results-earnings-call-transcript?page=1

All of the above highlights why Zacks continues their bullish stance on PBIO noting record quarterly revenues and expected significant revenue growth. See the full report here: http://scr.zacks.com/files/May-21-2015_PBIO_Zeng_v001_g65t02.pdf

With PBIOs investment into their sales and marketing departments along with their removal of variable-priced convertible debt, Zacks target price of $2.50 for PBIO
should come to fruition. Of course, investors need to do their own due
diligence, as there are always risks. However, because of the excellent
progress the company has recently made that has not yet been reflected
in the company’s stock price, we believe that PBIO presents an opportunity that could lead to strong, perhaps even remarkable investment gains in the very near future.

By: Callen Smith

SOURCE: Pressure BioSciences

ReleaseID: 430942

LOS ANGELES, CA / ACCESSWIRE / July 30, 2015 / GTX Corp (OTCBB: GTXO), an IoT platform in the personal location GPS wearable technology and wandering assistive technology business announced that current NFL offensive tackle Jason Fox and former NFL linebacker Colin McCarthy are joining the GTX Corp team as two of the Company’s newest athlete endorsers.

Jason Fox is in his sixth season as a NFL offensive tackle, currently playing with the Miami Dolphins. Fox states, “I’ve seen, firsthand, many concussions on the field. Working alongside a company like GTX Corp, keeps me in the important discussion about brain health. I’m excited to support solutions like GTX Corp’s GPS SmartSoles on behalf of myself and fellow players.”

Colin McCarthy is a former NFL linebacker for the Tennessee Titans. After experiencing injuries, McCarthy chose to retire from the NFL in 2015. McCarthy commented, “As a new athlete endorser to GTX Corp, I look forward to working with a company that utilizes their resources to benefit those who suffer from cognitive issues. I could be facing some of these brain health issues in the future, and I appreciate being a part of keeping those who are affected safe and being part of creating awareness for others who are at risk.”

Both athlete endorsers find that GTX Corp’s suite of GPS tracking technology products, including the GPS SmartSoles, will serve as a great way for them to stay “in the game” when it comes to awareness and discussions about Traumatic Brain Injuries (TBIs) and other cognitive ailments.

“We are excited to have Jason and Colin join our growing team of Athlete Brand Ambassadors,” stated Patrick Bertagna GTX Corp CEO. “Both Fox and McCarthy bring an element of reality and awareness to a very serious problem and through their advocacy can help us disseminate our message to a broader audience. Unfortunately, wandering is not confined just to seniors, many young adults are afflicted with TBI and autism, which both resemble Alzheimer’s and dementia in terms of the potential to become disoriented and lost.”

GTX Corp’s leading product, GPS SmartSoles are a stigma free, safety and security unobtrusive monitoring and tracking solution for those who suffer from Alzheimer’s, dementia, autism, TBI and other memory ailments and have a tendency to wander. The patented GPS SmartSoles, which were featured in AARP’s 2015 technology gear guide are placed in the wearer’s shoes and contain a GPS tracking chip connected through a cellular network that sends a signal to a central monitoring website or smart phone app, showing the exact location of the individual wearing them. They come in several trim to fit sizes for both men and women, are water resistant, made with the highest quality electronic components and assembled in Rhode Island, U.S.A.

GPS SmartSoles are available for consumer online purchase. SmartSoles the ;“where“in wearable tech.

About GTX Corp

GTX Corp (GTXO) is a pioneer in wearable technology and a leader in enterprise 2 way GPS real-time personal location based services. Headquartered in Los Angeles, California, GTX began marketing its SmartSoles less than a year ago and already has distribution in 13 countries. The Company is known for its game-changing and award-winning patented GPS Smart Shoe, blockbuster Smartphone GPS Tracking App, and innovative GPS SmartSole, GTX provides solutions that answer the “where” question: where is my mother, child, employee, vehicle, drone and high value assets.

Through a robust global enterprise monitoring platform and licensing subscription business model, the Company offers a complete end to end solution of location based hardware, middleware, apps, connectivity, and professional services. Letting you know where or how someone or something is at the touch of a button, delivering security and peace of mind in an instant. GTX Corp also owns and operates LOCiMOBILE, Inc which develops applications for smart phones and tablets and Code Amber Alertag. The Company has a comprehensive intellectual property strategy and owns an extensive portfolio of patents, patents pending, registered trademarks, copy rights and URL’s and was recently featured in a 38 page research piece which outlines the value proposition of the Company’s IP portfolio.

Online: www.gtxcorp.com www.gpssmartsole.com
Social media – #withyou
https://www.facebook.com/gtxcorpcom
http://www.twitter.com/gtxcorp
http://www.pinterest.com/GTXCorp/
http://instagram.com/gtxcorp

General information, licensing or investor relations email:

info@gtxcorp.com
213.489.3019
http://www.gtxcorp.com/about/licenseinquiry
ir@gtxcorp.com

Disclaimer: GTX Corp does not warrant or represent that the unauthorized use of materials drawn from the content of this document will not infringe rights of third parties who are not owned or affiliated by GTX Corp. Further GTX Corp cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.

Forward Looking Statements

This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by GTX in light of its experience and its perception of current conditions and expected future developments, as well as other factors that GTX believes are appropriate in the circumstances. Many factors could cause GTX’s actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are set forth in GTX’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained at http://www.sec.gov). These factors should be considered carefully, and readers should not place undue reliance on GTX’s forward-looking statements. GTX has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: GTX Corp.

ReleaseID: 430927

NEW YORK, NY / ACCESSWIRE / July 30, 2015 / Viggle Inc. (NASDAQ: VGGL), Millennial Media (NYSE: MM), and Rocket Fuel (NASDAQ: FUEL) are three tickers that have recently attracted attention in the tech space. With many analysts fearing a mean reversion in the sector, these three stocks appear to be straying from the general trend. Though all have experienced severe declines in their share price, fundamentals are surely to take over and help move the stocks ahead.

As in many other industries, the tech sector winners require several characteristics to continue to outpace their respective sectors. In technology, these characteristics include strong management backing, revenue generating products or services and the ability to be a visionary with financials. Most tech companies get to the stage of generating revenue, but cannot keep costs down in order to improve margins. Those that can get pass this financial hurdle can and will follow their own trajectory and continue to return even after the tech bubble has burst.

For a more detailed research report with analyst comments and recommendation on the Tech Sector please follow the link. There is no cost obligation required to view analyst brief.

http://bit.ly/_Tech_Sector_Report

About Broad Street Alerts

We make the connection between sophisticated investors and high quality micro and small cap companies. An issuer of reports that provide a straightforward assessment of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Safe Harbor Statement

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management’s own knowledge and assessment of the Company’s industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements.

Compliance Procedure

Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not hold any positions in profiled companies. For more information and services provided beyond this press release please use contact information provided below. If you notice any errors or omissions, please notify us.

Contact:
editor@broadstreetalerts.com

SOURCE: Broad Street Alerts

ReleaseID: 430907

VANCOUVER, BC / ACCESSWIRE / July 30, 2015 / Sunridge Gold Corp. (the “Company” or “Sunridge”) (TSX VENTURE: SGC OTCQX: SGCNF) is pleased to announce that it has executed an agreement with the Estate of Albert J Perry granting Sunridge a two-year option to purchase Perry’s 2% net profit interest (“NPI”) on Sunridge’s interest in the Asmara Project.

Albert J. Perry was a geologist that recognized the potential of the Asmara Project when he first visited the area in the 1990’s. Mr. Perry was granted a 2% NPI interest on the project by a previous operator and this interest has become the sole responsibility of Sunridge. Mr. Perry died in 2013 and his estate holds the NPI interest.

Sunridge will pay the Perry Estate a non-refundable payment of US$75,000 and is granted a one-year option to purchase the NPI interest for US$1.5 million. If Sunridge does not exercise this option within the first year then Sunridge has the option to pay the Perry Estate US$125,000 for the option to purchase the NPI interest for a second year for US$2.5 million.

This agreement with the Perry Estate quantifies the NPI and will help provide some certainty to future economics of the Asmara Project and will therefore assist in advancing all of AMSC’s future plans for the project.

The Asmara Project is held by the Asmara Mining Share Company (“AMSC”) a joint-venture company of which Sunridge owns 60% and the Eritrean National Mining Corporation (“ENAMCO”) owns 40%. The Asmara Project comprises six defined deposits, four of which are the subject of a feasibility study completed in May 2013 and are currently in the permitting process. The Perry Estate NPI applies to the entire Asmara Project but would be paid only by Sunridge from its share of cash flow from AMSC.

SUNRIDGE GOLD CORP.
“Michael Hopley”
Michael Hopley, President and Chief Executive Officer

For further information contact:
Greg Davis, VP Business Development

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements that are based on the Company’s current expectations and estimates. Forward-looking statements are frequently characterized by words such as “plan,” “expect,” “project,” “intend,” “believe,” “anticipate,” “estimate,” “suggest,” “indicate” and other similar words or statements that certain events or conditions “may” or “will” occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Forward looking statements may include the timing and success of any application for a mining license, permitting or of debt financing. Risk and uncertain factors include, among others: the actual results of current exploration activities; conclusions of economic evaluations; changes in project parameters as plans to continue to be refined; possible variations in ore grade or recovery rates; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals, a mining license, or debt financing, uncertainties in negotiating commercial arrangements with government entities; and fluctuations in metal prices. There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

SOURCE: Sunridge Gold Corp.

ReleaseID: 430947

Analyst Report on Antares Pharma, OraSure Technologies, and TransEnterix Inc.

NEW YORK, NY / ACCESSWIRE / July 30, 2015 / We went searching for value among small beaten down medical device companies with strong growth opportunities before them. Antares Pharma, Inc. (NASDAQ: ATRS), OraSure Technologies, Inc. (NASDAQ: OSUR) and TransEnterix Inc. (NYSE MKT: TRXC) are young companies with compelling products in development which could lead to strong future growth for the companies and profits for investors.

An analyst report on ATRS, OSUR, and TRXC that includes a company overview, valuation, and company analysis can be viewed by using the following link at no cost.

http://bit.ly/_Medical_Device_Sector_Report

Copy and paste to browser may be required.

About Broad Street Alerts

We make the connection between sophisticated investors and high quality micro and small cap companies. An issuer of reports that provide a straightforward assessment of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Safe Harbor Statement

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management’s own knowledge and assessment of the Company’s industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements.

Compliance Procedure

Content is researched, written and reviewed on a best-effort basis by a Michael McCord, Chartered Financial Analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below. If you notice any errors or omissions, please notify us.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

Contact:
editor@broadstreetalerts.com

SOURCE: Broad Street Alerts

ReleaseID: 430948